Treatment of cancer and hematological malignancy in elderly people (Part I);Prise en charge des cancers solides et des hémopathies malignes du sujet âgé: l'Oncogériatrie une discipline en devenir: Première partie: l'Évaluation gériatrique et la prise en charge des cancers solides

Revue de Medecine Interne

Volumn 26, Issue 3, 2005, Pages 216-225

  Ghiringhelli, F ^a,b   Ladoire, S ^a,b   Manckoundia, P ^c   Chauffert, B ^a,d   Solary, E ^a,e   Besancenot, J F ^b   Pfitzenmeyer, P ^c  

^a INSERM   (France)

^b HÔPITAL DU BOCAGE   (France)

^c Ctr Geriatrique de Champmaillot   (France)

^d Ctr Lutte Contre Cancer Georges F   (France)

^e Hôpital d'Enfant   (France)

Author keywords

Cancer; Elderly patients; Treatment

Indexed keywords

ANTHRACYCLINE; BEVACIZUMAB; BISPHOSPHONIC ACID DERIVATIVE; BLEOMYCIN; CAMPTOTHECIN; CAPECITABINE; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; FLUDARABINE; FLUOROURACIL; IFOSFAMIDE; MELPHALAN; METHOTREXATE; OXALIPLATIN; TAMOXIFEN; TEGAFUR;

CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HEMATOLOGIC MALIGNANCY; HORMONAL THERAPY; HUMAN; LIFE EXPECTANCY; MASTECTOMY; MEDICAL LITERATURE; METASTASIS; MORBIDITY; ONCOLOGY; REVIEW; RISK ASSESSMENT;

EID: 17044423835     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.10.021     Document Type: Short Survey

References (78)

1. R. Yancik, and L.A.G. Ries Aging and cancer in America: demographic and epidemiologic perspectives Hematol. Oncol. Clin. North Am. 14 2000 17 24
2. F. Levi, F. Lucchini, E. Negri, P. Boyle, and C. La Vecchia Changed trends of cancer mortality in the elderly Ann. Oncol. 12 2001 1467 1477
3. M.S. Egorrin Cancer pharmacology in the elderly Semin. Oncol. 20 1993 43 49
4. N.S. Scrimshaw, and R.M. Suskind Interactions of nutrition and infection Dent. Clin. North Am. 20 1976 461 472
5. B. Desoize, and J. Robert Individual dose adaptation of anticancer drugs Eur. J. Cancer 30 1994 844 851
6. R.S. Gelman, and S.G. Taylor C.M.F. chemotherapy in women more than 65:years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance J. Clin. Oncol. 2 1984 1406 1414
7. J.C. Gorski, S. Vannaprasaht, M.A. Hamman, W.T. Ambrosius, M.A. Bruce, and B. Haehner-Daniels The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity Clin. Pharmacol. Ther. 74 2003 275 287
8. M.D. Murray, and C.M. Callahan Improving medication use for older adults: an integrated research agenda Ann. Intern. Med. 139 2003 425 429
9. L. Balducci, and G. Yates General guidelines for the management of older patients with cancer. Oncology, NCCN Proceedings 2000 221 227
10. M. Bjorkholm, E. Osby, and H. Hagberg Randomized trial of R-methu granocyte colony stimulating factors as adjunction to CHOP or CNOP treatment of elderly patients with aggressive non Hodgkin's lymphoma Proc. ASH, Blood 94 suppl 1999 599a (Abstr 2665)
11. L. Balducci, C.H. Hardy, and G.H. Lyman Hematopoietic growth factors in the older cancer patient Curr. Op. Hematol. 8 2001 170 187
12. S.D. Jacobson, S. Cha, and D.J. Sargent Tolerability, dose intensity and benefit of 5FU based chemotherapy for advanced colorectal cancer in the elderly. A North Central Cancer Treatment Group Study Proc. Am. Soc. Clin. Oncol. 384a 2001 (Abst 1534)
13. R. Mattioli, P. Lippe, F. Recchia, C. Massacesi, L. Imperatori, and S. De Filippis Advanced colorectal cancer in elderly patients: tolerance and efficacy of leucovorin and fluorouracil bolus plus continuous infusion Anticancer Res. 21 2001 489 492
14. J. Drevs, M. Medinger, C. Schmidt-Gersbach, R. Weber, and C. Unger Receptor tyrosine kinases: the main targets for new anticancer therapy Curr. Drug. Targets 4 2003 113 121
15. C.L. Willman The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: Studies of the Southwest Oncology Group Leukemia Research program Semin. Hematol. 34 1997 25 36
16. L. Repetto, and L. Balducci A case for geriatic oncology Lancet Oncol. 3 2002 289 297
17. L. Balducci, and G. Yates General guidelines for the management of older patients with cancer Oncol NCCN 14 2000 221 227
18. P.A. Parmelee, P.D. Thuras, I.R. Katz, and M.P. Lawton Validation of the Cumulative Illness Rate Scale in geriatric residential population J. Am. Geriatr. Soc. 43 1995 130 137
19. L.P. Fried, C.M. Tangen, J. Walston, A.B. Newman, C. Hirsch, and J. Gottdiener Frailty in older adults. Evidence for a phenotype J. Gerontol. A Biol. Sci. Med. Sci. 56 2001 M146 M156
20. D. Saliba, M. Elliott, L.Z. Rubenstein, D.H. Solomon, R.T. Young, and C.J. Kamberg The vulnerable elders survey: a tool for identifying vulnerable older people in the community J. Am. Ger. Soc. 49 2001 1691 1699
21. L. Balducci, and G. Santa Cancer in the frail patient: a coming epidemic Hematol. Oncol. Clin. North Am. 14 2000 235 250
22. H.J. Cohen, C.F. Pieper, and T. Harris Markers of inflammation and coagulation predict decline in function and mortality in community dwelling elderly Proc. Am. Ger. Soc. S1 2001 (Abstr A3)
23. D. Hamermann Toward an understanding of frailty Ann. Intern. Med. 130 1999 945 950
24. L. Balducci, and I. Carreca Oral chemotherapy of cancer in the elderly Am. J. Cancer 1 2002 101 108
25. L. Balducci, and M. Extermann Management of the frail person with advanced cancer Crit. Rev. Oncol. Hematol. 14 2000 143 148
26. L.S. McGinnis Surgical treatment options for colorectal cancer Cancer 1 74 1994 2147 2150
27. J. Papillon Rectal and anal cancers. Conservative treatment by irradiation. An alternative radical surgery 1982 Springer-Verlag Berlin
28. A. Arora, and J. Potter Older patients with colon cancer: is adjuvant chemotherapy safe and effective? J. Am. Geriatr. Soc. 51 2003 567 569
29. T.J. Iwashyna, and E.B. Lamont Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer J. Clin. Oncol. 20 2002 3992 3998
30. S. Monfardini, and B. Chabner Joint NCI-EORTC consensus meeting on neoplasia in the elderly San Servolo Island, Venice, 15-16 October 1990 Eur. J. Cancer 27 1991 653 654
31. W. Scheithauer, H. Rosen, G.V. Kornek, C. Sebesta, and D. Depisch Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer BMJ 306 1993 752
32. M.T. Nobile, M.C. Barzacch, O. Sanguineti, S. Chiara, A. Gozza, and M. Vincenti Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer Anticancer Res. 18 1998 517 518
33. B.N. Stein, N.J. Petrilli, H.O. Douglass, D.L. Driscoll, G. Arcangeli, and N.J. Meropol Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial Cancer 75 1995 11 17
34. S. Chiara, M.T. Nobile, M. Vincenti, R. Lionetto, A. Gozza, and M.C. Barzacchi Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil based chemotherapy Cancer Chemother. Pharmacol. 42 1998 336 340
35. A. de Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, and J. Cassidy Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J. Clin. Oncol. 18 2000 2938 2947
36. A. Romiti, G. Tonini, D. Santini, M. Di Seri, R. Masciangelo, and S. Mezi Tolerability of ralitrexed (tomudex) in elderly patients with colorectal cancer Anticancer Res. 22 2002 3071 3076
37. F. Franchi, C. Pastore, A. Caporale, O. Fabiani, L. Rossi, and T. Seminara Favorable toxicity profile of ralitrexed in elderly patients treated for colorectal cancer: a case series Gerontology 49 2003 324 327
38. C. Delbaldo, S. Faivre, and E. Raymond Inhibiteurs du ŕcepteur ̀ l'EGF Rev. Med. Interne 24 2003 372 383
39. G. Mustacchi, S. Milani, A. Pluchinotta, A. De Matteis, A. Rubagotti, and A. Perrota Tamoxifen or surgery plus tamoxifen as treatment for elderly patients with operable breast cancer. The GRETA trial Group for Research on Endocrine therapy in the elderly Anticancer Res. 14 1994 2197 2200
40. E. Galante, A.M. Cerrotta, and A. Crippa Outpatient treatment of clinically node-negative breast cancer in the elderly Cancer Control 1 1994 344 349
41. D.E. Wazer, J.K. Erban, N.J. Robert, T.J. Smith, D.J. Marchant, and C. Schmid Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection Cancer 74 1994 878 883
42. D.W. Ollila, and K.B. Stitzenberg Breast cancer sentinel node metastases: histopathologic detection and clinical significance Cancer Control 8 2001 407 414
43. Early Breast Cancer Trialists' Collaborative Group Tamoxifen for early breast cancer: an overview of the randomised trials Lancet 351 1998 1451 1467
44. B. Fisher, J.P. Costantino, C.K. Redmond, E.R. Fisher, D.L. Wickerham, and W.M. Cronin Endometrial cancer in tamoxifen treated breast cancer patients: findings from the national surgical adjuvant breast and bowel project (NSABP) B-14 J. Natl. Cancer Inst. 86 1994 527 537
45. N. Terakawa Approaches targeted to estrogen receptors for treatment of tamoxifen resistant breast cancer: a brief overview Oncology 59 2000 3 4
46. B. Fisher, J. Bryant, J.J. Dignam, D.L. Wickerham, E.P. Mamounas, and E.R. Fisher Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less J. Clin. Oncol 20 2002 4141 4149
47. J.A. Wils, J.M. Bliss, M. Marty, G. Coombes, C. Fontaine, and F. Morvan Epirubicin plus tamoxifen versus tamoxifen alone in node positive postmenopausal patients with breast cancer: a randomised trial of the international collaborative cancer group J. Clin. Oncol. 17 1999 1988 1998
48. G.N. Hortobagyi Treatment of breast cancer N. Engl. J. Med. 339 1998 974 984
49. S.G. Taylor, R.S. Gelman, G. Falkson, and F.J. Cummings Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer elderly women Ann. Inter.Med. 104 1986 455 461
50. E.C. Dee, S. O'Reilly, S.N. Goodman, S. Sartorius, M.A. Levine, and R.J. Jones A prospective pharmacologic evaluation of age related toxicity of adjuvant chemotherapy in women with breast cancer Cancer Invest. 18 2000 521 529
51. B. Chevalier Phase II study of pirarubicin (THP) in elderly, hormone refractory women with advanced breast cancer Proceedings XVth congress ESMO 24 1990 3
52. M. Hery Traitement des tumeurs du sujet âǵ 2003 Masson Paris
53. E. Rivera, V. Valero, B. Arun, M. Royce, R. Adinin, and K. Hoelzer Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer J. Clin. Oncol. 21 2003 3249 3254
54. J.M. Nabholtz, J.M. Vannetzel, J.F. Llory, and P. Bouffette Advances in the use of taxanes in the adjuvant therapy of breast cancer Clin. Breast Cancer 4 2003 187 192
55. A.D. Seidman, J. O'Shaughnessy, and J.L. Misset Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer? Oncologist 7 2002 20 28
56. L. Zelek, S. Barthier, M. Riofrio, K. Fizazi, O. Rixe, and J.P. Delord Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma Cancer 1 2001 2267 2272
57. M. Jahanzeb Trastuzumab-based combinations in metastatic breast cancer: how to make a choice Clin. Breast Cancer 4 2003 28 38
58. C.J. Langer, J. Manola, P. Bernardo, J.W. Kugler, P. Bonomi, and D. Cella Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial J. Natl Cancer Inst. 94 2002 173 181
59. K. Kelly, J. Crowley, P.A. Bunn Jr., C.A. Presant, P.K. Grevstad, and C.M. Moinpour Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non - small-cell lung cancer: a Southwest Oncology Group trial J. clin. Oncol. 19 2001 3210 3218
60. P. Warde, and D. Payne Does thoracic irradiation improve survival and local control n limited stage small cell carcinoma of the lung? A meta analysis J. Clin. Oncol. 10 1992 890 895
61. A. Auperin, R. Arriagada, J.P. Pignon, C. Le Pechoux, A. Gregor, and R.J. Stephens Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission N. Engl. J. Med. 341 1999 476 484
62. J.P. Pignon, R. Arriagada, D.C. Ihde, D.H. Johnson, M.C. Perry, and R.L. Souhami A meta analysis of thoracic radiotherapy for small cell lung cancer N. Engl. J. Med. 327 1992 1618 1624
63. E. Dajczman, L.Y. Fu, D. Small, N. Wolkove, and H. Kreisman Treatment of mall cell lung cancer carcinoma in the elderly Cancer 77 1996 2032 2238
64. B. Jeremic, Y. Shibamoto, L. Acimovic, and S. Milisavljevic Carboplatin, etoposide and acelerated hyperfractionated radiotherapy for elderly patients with limited small cell lug carcinoma: a phase II study Cancer 82 1998 836 841
65. Y. Mizushima, T. Kashii, Y. Yoshida, S. Sugiyma, and M. Kobayashi Characteristics of lung cancer in the elderly Anticancer Res. 16 1996 3181 3184
66. L.C. Demaria Jr., and H.J. Cohen Characteristics of lung cancer in the elderly patients J. Gerontol. 42 1987 540 545
67. M. Montella, C. Gridelli, A. Crispo, F. Scognamiglio, P. Ruffolo, and T. Gatani Has lung cancer in the elderly different characteristics at presentation? Oncol. Rep. 9 2002 1093 1096
68. T. Osaki, T. Shirakusa, M. Kodate, R. Nakanishi, T. Mitsudomi, and H. Ueda Surgical treatment of lung cancer in octagenarian Ann. Thorac. Surg. 57 1994 188 193
69. E.M. Noodijk, E.V.D. Poest Clement, J. Hermans, A.M.J. Wever, and J.W.K. Leer Radiotherapy as an alternative to surgery in elderly patients with respectable lung cancer Radiother. Oncol. 13 1988 83 89
70. C. Schaake-Koning, W. Van den Bogaert, O. Dalesio, O. Dalesio, J. Festen, and J. Hoogenhout Effects of concomitant cisplatin and radiotherapy on inoperable non small cell lung cancer N. Engl. J. Med. 326 1992 524 530
71. B. Movsas, C. Scott, W. Sause, R. Byhardt, R. Komaki, and J. Cox The benefit of treatment intensification is age and histology dependant in patients with locally advanced non small cell lung cancer: a quality adjusted survival analysis of Radiation Therapy Oncology Group chemoradiation studies Int. Radiat. Oncol. Bio. Phys. 45 1999 1143 1149
72. F. Perrone, C. Gallo, and C. Gridelli Cisplatin based therapy for elderly patients with advanced non small cell lung cancer: implication of Eastern Cooperative Oncology Group: a randomized trial J. Natl. Cancer Inst. 94 2002 1029 1031
73. C. Gridelli, F. Perrone, C. Gallo, F. De Marinis, G. Ianniello, and S. Cigolari Vinorelbine is well tolerated and active treatment of elderly patients with advanced non small cell lung cancer Eur. J. Cancer 33 1997 307 392
74. T. Le Chevalier Single agent activity of gemcitabine in advanced non small cell lung cancer Semin. Oncol. 23 1996 36 42
75. F.A. Sheperd, R. Abratt, L. Crino, M. Green, A. Sandler, and W. Steward The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-smann cell lung cancer Lung Cancer 30 2000 117 125
76. G.D. Beretta, G. Michetti, M.O. Belometti, G. Gritti, A. Quadri, and P. Poletti Gemcitabine plus vinorelbine in elderly or unfit patients with non small cell lung cancer Br. J. Cancer 83 2000 573 576
77. G. Frasci, V. Lorusso, N. Panza, P. Comella, G. Nicolella, and A. Bianco Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non small cell lung cancer J. Clin. Oncol. 18 2000 2529 2536
78. M. Ranson, N. Davidson, M. Nicolson, S. Falk, J. Carmichael, and P. Lopez Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non small cell lung cancer J. Natl. Cancer Inst. 92 2000 1074 1080